PhytoHealth (4108) Monthly Revenue

Market: TWSE-listed · Industry: Biotech & Medical · 懷特

PhytoHealth (4108) reported revenue of NT$13.7 million for Oct 2026, +6.0% year on year and +15.3% from the previous month. Revenue for Jan–Oct 2026 was NT$120.5 million (+5.4% year on year).

In Oct 2026, it ranked No. 129 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$9.5 million24/10Nov 2024 NT$13.6 millionDec 2024 NT$14 millionJan 2025 NT$9.2 millionFeb 2025 NT$8.8 million25/02Mar 2025 NT$12.5 millionApr 2025 NT$9.8 millionMay 2025 NT$10 millionJun 2025 NT$11.2 million25/06Jul 2025 NT$12.4 millionAug 2025 NT$10.1 millionSep 2025 NT$17.4 millionOct 2025 NT$12.9 million25/10Nov 2025 NT$11.6 millionDec 2025 NT$8.6 millionJan 2026 NT$15.4 millionFeb 2026 NT$9.2 million26/02Mar 2026 NT$9.9 millionApr 2026 NT$9.8 millionMay 2026 NT$11.9 millionJun 2026 NT$14.3 million26/06Jul 2026 NT$11.9 millionAug 2026 NT$12.7 millionSep 2026 NT$11.9 millionOct 2026 NT$13.7 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$13.7 million+6.0%+15.3%
Sep 2026NT$11.9 million-31.8%-6.5%
Aug 2026NT$12.7 million+25.8%+6.6%
Jul 2026NT$11.9 million-4.1%-16.7%
Jun 2026NT$14.3 million+27.8%+20.3%
May 2026NT$11.9 million+18.5%+21.7%
Apr 2026NT$9.8 million-0.8%-1.0%
Mar 2026NT$9.9 million-21.4%+6.9%
Feb 2026NT$9.2 million+5.0%-40.2%
Jan 2026NT$15.4 million+67.6%+79.5%
Dec 2025NT$8.6 million-38.5%-26.2%
Nov 2025NT$11.6 million-14.1%-9.7%
Oct 2025NT$12.9 million+35.9%-25.8%
Sep 2025NT$17.4 million+10.9%+72.7%
Aug 2025NT$10.1 million-3.8%-18.8%
Jul 2025NT$12.4 million-9.2%+10.9%
Jun 2025NT$11.2 million-35.8%+11.5%
May 2025NT$10 million-40.1%+1.9%
Apr 2025NT$9.8 million-1.5%-21.6%
Mar 2025NT$12.5 million+24.8%+42.8%
Feb 2025NT$8.8 million-9.8%-4.6%
Jan 2025NT$9.2 million-28.0%-34.2%
Dec 2024NT$14 million-21.6%+3.2%
Nov 2024NT$13.6 million+7.3%+42.8%
Oct 2024NT$9.5 million-41.2%-39.5%

Jan–Oct 2026 cumulative: NT$120.5 million (+5.4% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: PhytoHealth vs PEC / PhytoHealth vs Lotus Pharm / PhytoHealth vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16